Biocon expects stronger FY27, growth momentum to accelerate soon
Biocon reported a consolidated net profit of Rs 141 crore for Q1 FY27, up from Rs 31 crore YoY. Revenue rose 10% to Rs 4,336 crore. The company expects a stronger FY27 with accelerated growth, especially in its biosimilars business in H2. Biocon expects to deliver a stronger performance as FY27 progresses, with growth momentum … Read more